版本:
中国

BRIEF-Sanofi and Regeneron announce FDA approval of a once-monthly dosing option for Praluent

April 25 Sanofi

* Sanofi and Regeneron announce FDA approval of a new once-monthly dosing option for Praluent (alirocumab) injection

* Sanofi and Regeneron announce FDA approval of a new once-monthly dosing option for Praluent (alirocumab) injection

* Monthly dosing schedule now approved in both United States and European Union Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐